Published • loading... • Updated
Jaguar LAA Acquires Laminar Program Assets From Johnson & Johnson
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Jaguar LAA Acquires Laminar Program Assets From Johnson & Johnson
Jaguar LAA has acquired assets related to Johnson & Johnson‘s Laminar program, a medical device technology being developed for left atrial appendage closure in patients with non-valvular atrial fibrillation. The transaction transfers key Laminar assets and members of the program’s development team to Jaguar, a newly formed independent medical device company. Jaguar plans to continue the program’s clinical and development work and advance the tec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
